Performance Validity and Outcome of Cognitive Behavior Therapy in Patients with Chronic Fatigue Syndrome.
Roor, Jeroen J, Dandachi-FitzGerald, Brechje, Peters, Maarten J V et al. · Journal of the International Neuropsychological Society : JINS · 2022 · DOI
Quick Summary
This study looked at whether certain types of memory test performance could predict how well people with ME/CFS would respond to cognitive behavioral therapy (CBT). Researchers tested 1,081 patients before and after CBT treatment. While test scores didn't predict treatment outcomes for people who stuck with the program, patients with lower test scores were more likely to drop out of treatment early. The key finding is that if people with lower scores stayed in treatment, they actually improved just as much as others.
Why It Matters
This research addresses an important clinical question about which ME/CFS patients may struggle with CBT engagement, helping clinicians identify those at risk for dropout and potentially modify interventions to improve retention. The finding that lower cognitive test performance doesn't impair treatment response in completers challenges assumptions about who can benefit from CBT for ME/CFS and suggests barriers to engagement warrant targeted attention rather than exclusion.
Observed Findings
Lower baseline ASTM scores were significantly associated with missing follow-up assessments and fewer completed therapy sessions.
Patients with lower ASTM performance reported higher levels of physical limitations at baseline.
Among patients who completed treatment and follow-up, ASTM scores at baseline did not significantly predict CBT outcomes across fatigue, disability, psychological distress, or functional impairment measures.
Dropout and incomplete follow-up were the primary differentiators for lower-scoring patients, not treatment response.
Inferred Conclusions
Performance validity testing predicts treatment engagement and adherence rather than treatment responsiveness in ME/CFS patients undergoing CBT.
CBS patients with lower cognitive test performance who remain in treatment achieve comparable improvement to those with higher scores, indicating they can benefit from CBT if retained.
Understanding and addressing adherence barriers in lower-scoring patients may unlock treatment benefits in a potentially vulnerable subgroup.
Remaining Questions
What specific factors (cognitive, motivational, symptom-related, or systemic) drive the higher dropout rate in patients with lower ASTM scores?
Would targeted retention strategies or treatment modifications for lower-scoring patients improve engagement without compromising outcomes?
What This Study Does Not Prove
This study does not establish that poor test performance *causes* treatment dropout; it only shows an association. The study cannot determine why lower-scoring patients had higher dropout rates (whether due to cognitive factors, symptom severity, motivation, or other unmeasured variables). The results also may not generalize to all CBT programs for ME/CFS, as this was a specific clinical sample.
Tags
Symptom:Cognitive DysfunctionFatigue
Method Flag:Weak Case DefinitionNo ControlsMixed Cohort